CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$54.83 -0.61 (-1.11%)
As of: Oct 2, 2026 · 3:04 PM EDT

CRISPR Therapeutics AG (CRSP) Non-Current Deffered Revenue (2015 - 2025)

Updated

CRISPR Therapeutics AG (CRSP) posted Non-Current Deffered Revenue of $12.32 million for Q3 2025, unchanged from $12.32 million a year earlier and unchanged from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) Non-Current Deffered Revenue (2015 - 2025) Analysis & Trends

Since Q4 2015, CRISPR Therapeutics AG has reported Non-Current Deffered Revenue for 38 quarters.

  • Annual Non-Current Deffered Revenue shows a five-year compound annual growth rate of 0.9% (FY2019 to FY2024).
  • In prior years, CRISPR Therapeutics AG's Non-Current Deffered Revenue was $14.01 million in FY2023 (+13.7%), $12.32 million in FY2022 (unchanged), $12.32 million in FY2021 (+4.6%) and $11.78 million in FY2020 (unchanged).
  • Quarterly Non-Current Deffered Revenue has run from a low of $11.78 million in Q2 2021 to a high of $15.82 million in Q3 2023 over five years.
  • On a year-over-year basis, Non-Current Deffered Revenue increased in three of the last eight quarters, with an average decline of 2.4%.
  • The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was Q3 2023, with growth of 28.4%; the weakest was Q3 2024, with a decline of 22.1%.
  • According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $12.32 million (Q2 2025), $12.32 million (Q1 2025) and $12.32 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 CRISPR Therapeutics AG 5.35 Bn 5.35 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 12.32 Mn
Jun 30, 2025 12.32 Mn
Mar 31, 2025 12.32 Mn
Dec 31, 2024 12.32 Mn
Sep 30, 2024 12.32 Mn
Jun 30, 2024 12.58 Mn
Mar 31, 2024 13.54 Mn
Dec 31, 2023 14.01 Mn
Sep 30, 2023 15.82 Mn
Jun 30, 2023 12.32 Mn
Mar 31, 2023 12.32 Mn
Dec 31, 2022 12.32 Mn
Sep 30, 2022 12.32 Mn
Jun 30, 2022 12.32 Mn
Mar 31, 2022 12.32 Mn
Dec 31, 2021 12.32 Mn
Sep 30, 2021 11.78 Mn
Jun 30, 2021 11.78 Mn
Mar 31, 2021 11.78 Mn
Dec 31, 2020 11.78 Mn
API Access

CRISPR Therapeutics AG Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CRSP&period=max&api_key=YOUR_API_KEY